Masuo Yamaoka

1.3k citations

24 papers · 1.0k indexed · h-index 17

Pulmonary and Respiratory Medicine top 5%
Endocrinology, Diabetes and Metabolism top 5%
Molecular Biology
Genetics top 10%
Cancer Research top 10%

Co-authors: Takahito Hara Masami Kusaka Hideo Araki Naoyuki Kanzaki Jun‐ichi Miyazaki Masaomi Miyamoto Tomohiro Kaku Akihiro Tasaka
Topics: Prostate Cancer Treatment and Research (15 papers)Hormonal and reproductive studies (14 papers)Estrogen and related hormone effects (7 papers)
Cited by: Endocrinology, Diabetes and Metabolism Pulmonary and Respiratory Medicine Cancer Research
Journals: PLoS ONE Clinical Cancer Research European Journal of Pharmacology
Partner nations: Japan United States

In The Last Decade

Masuo Yamaoka

24 papers receiving 1.0k citations

Peers

Countries citing papers authored by Masuo Yamaoka

Since Specialization

Citations

This map shows the geographic impact of Masuo Yamaoka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masuo Yamaoka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masuo Yamaoka more than expected).

Fields of papers citing papers by Masuo Yamaoka

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masuo Yamaoka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masuo Yamaoka. The network helps show where Masuo Yamaoka may publish in the future.

Co-authorship network of co-authors of Masuo Yamaoka

This figure shows the co-authorship network connecting the top 25 collaborators of Masuo Yamaoka. A scholar is included among the top collaborators of Masuo Yamaoka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masuo Yamaoka. Masuo Yamaoka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A selective androgen receptor modulator SARM‐2f activates androgen receptor, increases lean body mass, and suppresses blood lipid levels in cynomolgus monkeys 2020 ·Pharmacology Research & Perspectives ·Megumi Morimoto,Masuo Yamaoka,Takahito Hara	12
2	Synthesis and biological evaluation of novel selective androgen receptor modulators (SARMs) Part III: Discovery of 4-(5-oxopyrrolidine-1-yl)benzonitrile derivative 2f as a clinical candidate 2017 ·Bioorganic & Medicinal Chemistry ·Katsuji Aikawa,(unknown),Koji Ono,Noriyuki Habuka,Jason K. Yano,Keith P. Wilson,Hisashi Fujita,Hitoshi Kandori,Takahito Hara,Megumi Morimoto,Takashi Santou,Masuo Yamaoka,Masaaki Nakayama,Atsushi Hasuoka	36
3	Amelioration of sexual behavior and motor activity deficits in a castrated rodent model with a selective androgen receptor modulator SARM-2f 2017 ·PLoS ONE ·Megumi Morimoto,Yuichiro Amano,Masahiro Oka,Ayako Harada,Hisashi Fujita,(unknown),Ryuichi Tozawa,Masuo Yamaoka,Takahito Hara	16
4	Synthesis and biological evaluation of novel selective androgen receptor modulators (SARMs). Part II: Optimization of 4-(pyrrolidin-1-yl)benzonitrile derivatives 2017 ·Bioorganic & Medicinal Chemistry Letters ·(unknown),Takenori Hitaka,Takashi Imada,Masami Yamada,Megumi Morimoto,(unknown),Takahito Hara,Masuo Yamaoka,Takashi Santou,Masaaki Nakayama,Yumi Imai,Noriyuki Habuka,Jason K. Yano,Keith P. Wilson,Hisashi Fujita,Atsushi Hasuoka	15
5	Synthesis and biological evaluation of novel selective androgen receptor modulators (SARMs). Part I 2015 ·Bioorganic & Medicinal Chemistry ·Katsuji Aikawa,(unknown),Takenori Hitaka,Yumi Imai,Takahito Hara,Jun‐ichi Miyazaki,Masuo Yamaoka,Masami Kusaka,Naoyuki Kanzaki,Akihiro Tasaka,Mitsuru Shiraishi,Satoshi Yamamoto	19
6	Selective androgen receptor modulator activity of a steroidal antiandrogen TSAA-291 and its cofactor recruitment profile 2015 ·European Journal of Pharmacology ·(unknown),Masuo Yamaoka,Masami Kusaka,Takahito Hara	16
7	Effect of an investigational CYP17A1 inhibitor, orteronel (TAK-700), on estrogen- and corticoid-synthesis pathways in hypophysectomized female rats and on the serum estradiol levels in female cynomolgus monkeys 2013 ·The Journal of Steroid Biochemistry and Molecular Biology ·Masuo Yamaoka,Takahito Hara,Hideo Araki,Tomohiro Kaku,Takenori Hitaka,Akihiro Tasaka,Masami Kusaka	6
8	Orteronel (TAK-700), a novel non-steroidal 17,20-lyase inhibitor: Effects on steroid synthesis in human and monkey adrenal cells and serum steroid levels in cynomolgus monkeys 2012 ·The Journal of Steroid Biochemistry and Molecular Biology ·Masuo Yamaoka,Takahito Hara,Takenori Hitaka,Tomohiro Kaku,Toshiyuki Takeuchi,Junzo Takahashi,Satoru Asahi,Hiroshi Miki,Akihiro Tasaka,Masami Kusaka	98
9	Effect of a novel 17,20-lyase inhibitor, orteronel (TAK-700), on androgen synthesis in male rats 2012 ·The Journal of Steroid Biochemistry and Molecular Biology ·Takahito Hara,(unknown),Tomohiro Kaku,Toshiyuki Takeuchi,Masami Kusaka,Akihiro Tasaka,Masuo Yamaoka	28
10	Design, synthesis, and biological evaluation of 4-arylmethyl-1-phenylpyrazole and 4-aryloxy-1-phenylpyrazole derivatives as novel androgen receptor antagonists 2012 ·Bioorganic & Medicinal Chemistry ·Satoshi Yamamoto,Naoki Tomita,(unknown),(unknown),Tomohiro Kaku,Takahito Hara,Masuo Yamaoka,Naoyuki Kanzaki,Atsushi Hasuoka,Atsuo Baba,Mitsuhiro Ito	25
11	Design, synthesis, and biological evaluation of 3-aryl-3-hydroxy-1-phenylpyrrolidine derivatives as novel androgen receptor antagonists 2012 ·Bioorganic & Medicinal Chemistry ·Satoshi Yamamoto,Hiromi Kobayashi,Tomohiro Kaku,Katsuji Aikawa,Takahito Hara,Masuo Yamaoka,Naoyuki Kanzaki,Atsushi Hasuoka,Atsuo Baba,Mitsuhiro Ito	9
12	Design, synthesis, and biological evaluation of 4-phenylpyrrole derivatives as novel androgen receptor antagonists 2011 ·Bioorganic & Medicinal Chemistry ·Satoshi Yamamoto,Nobuyuki Matsunaga,Takenori Hitaka,Masami Yamada,Takahito Hara,Jun‐ichi Miyazaki,Takashi Santou,Masami Kusaka,Masuo Yamaoka,Naoyuki Kanzaki,Shuichi Furuya,Akihiro Tasaka,(unknown),Mitsuhiro Ito	18
13	17,20-Lyase inhibitors. Part 4: Design, synthesis and structure–activity relationships of naphthylmethylimidazole derivatives as novel 17,20-lyase inhibitors 2011 ·Bioorganic & Medicinal Chemistry ·Tomohiro Kaku,Nobuyuki Matsunaga,Akio Ojida,Toshimasa Tanaka,Takahito Hara,Masuo Yamaoka,Masami Kusaka,Akihiro Tasaka	8
14	Discovery of orteronel (TAK-700), a naphthylmethylimidazole derivative, as a highly selective 17,20-lyase inhibitor with potential utility in the treatment of prostate cancer 2011 ·Bioorganic & Medicinal Chemistry ·Tomohiro Kaku,Takenori Hitaka,Akio Ojida,Nobuyuki Matsunaga,(unknown),Toshimasa Tanaka,Takahito Hara,Masuo Yamaoka,Masami Kusaka,Teruaki Okuda,Satoru Asahi,Shuichi Furuya,Akihiro Tasaka	103
15	17,20-Lyase inhibitors. Part 3: Design, synthesis, and structure–activity relationships of biphenylylmethylimidazole derivatives as novel 17,20-lyase inhibitors 2011 ·Bioorganic & Medicinal Chemistry ·Tomohiro Kaku,(unknown),Nobuyuki Matsunaga,Toshimasa Tanaka,Takahito Hara,Masuo Yamaoka,Masami Kusaka,Akihiro Tasaka	4
16	A mutation in β‐tubulin and a sustained dependence on androgen receptor signalling in a newly established docetaxel‐resistant prostate cancer cell line 2009 ·Cell Biology International ·Takahito Hara,(unknown),(unknown),(unknown),Hideo Araki,(unknown),Masahiko Hattori,Yumi Imai,Masuo Yamaoka	33
17	Possible role of adaptive mutation in resistance to antiandrogen in prostate cancer cells 2005 ·The Prostate ·Takahito Hara,(unknown),Kazuyo Nakamura,Masami Kusaka,Masuo Yamaoka	27
18	C17,20-lyase inhibitors. Part 2: Design, synthesis and structure–activity relationships of (2-naphthylmethyl)-1H-imidazoles as novel C17,20-lyase inhibitors 2004 ·Bioorganic & Medicinal Chemistry ·Nobuyuki Matsunaga,Tomohiro Kaku,Akio Ojida,Toshimasa Tanaka,Takahito Hara,Masuo Yamaoka,Masami Kusaka,Akihiro Tasaka	47
19	C17,20-Lyase inhibitors I. Structure-based de novo design and SAR study of C17,20-lyase inhibitors 2004 ·Bioorganic & Medicinal Chemistry ·Nobuyuki Matsunaga,Tomohiro Kaku,Fumio Itoh,Toshimasa Tanaka,Takahito Hara,Hiroshi Miki,M. Iwasaki,(unknown),Masuo Yamaoka,Masami Kusaka,Akihiro Tasaka	34
20	Acceleration of wound healing by recombinant human basic fibroblast growth factor in a rat sponge-implantation model. 1991 ·Ensho ·Masuo Yamaoka,Tsuneo Masaki,Katsuichi Sudo,Akio Shino,(unknown)	8

About Masuo Yamaoka

Masuo Yamaoka is a scholar working on Endocrinology, Diabetes and Metabolism, Pulmonary and Respiratory Medicine and Genetics, having authored 24 papers that have together received 1.0k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (15 papers), Hormonal and reproductive studies (14 papers) and Estrogen and related hormone effects (7 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (413 citations), Pulmonary and Respiratory Medicine (651 citations) and Cancer Research (192 citations). Masuo Yamaoka has collaborated with scholars based in Japan and United States. Frequent co-authors include Takahito Hara, Masami Kusaka, Hideo Araki, Naoyuki Kanzaki, Jun‐ichi Miyazaki, Masaomi Miyamoto, Tomohiro Kaku, Akihiro Tasaka, Takenori Hitaka and Nobuyuki Matsunaga. Their work appears in journals such as PLoS ONE, Clinical Cancer Research and European Journal of Pharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact